Cel Sci (CVM) Asset Writedowns and Impairment (2021 - 2025)

Cel Sci has reported Asset Writedowns and Impairment for 5 years, with the latest figure at -$1046.0 in Q1 2025.

• Quarterly Asset Writedowns and Impairment fell 155.67% year-over-year to -$1046.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$421.0 (down 104.16% YoY) and the FY2024 annual result came in at $4873.0, down 68.13% from the prior year.
• Asset Writedowns and Impairment declined to -$1046.0 in Q1 2025 per CVM's latest filing, from $135.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $31441.0 in Q3 2021 and troughed at -$18597.0 in Q3 2022.
• A 5-year average of $5432.5 and a median of $2504.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment plunged 159.15% in 2022, then jumped 113.46% in 2023.
• Over 5 years, Asset Writedowns and Impairment stood at $24997.0 in 2021, then slumped by 79.69% to $5078.0 in 2022, then sank by 50.69% to $2504.0 in 2023, then sank by 94.61% to $135.0 in 2024, then tumbled by 874.81% to -$1046.0 in 2025.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$1046.0, $135.0, and -$135.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.